Call us 24/7

Gynecologic Cancer Program

Our program

The Gynecologic Cancer Program at Cancer Treatment Centers of America® (CTCA), Chicago, specializes in treating women with cancer of the reproductive organs. Our multidisciplinary team of board-certified gynecologic oncologists, surgical oncologists and radiation oncologists work together with supportive care clinicians and with our patients to deliver quality clinical care with a patient-centered approach.

Our Gynecologic Cancer Program treats all gynecologic cancers including cervical, endometrial (uterine), fallopian tube, gestational trophoblastic disease (GTD), ovarian, vaginal and vulvar.

Treatment for women diagnosed with a gynecologic cancer typically depends on many factors, such as the type and stage of the disease, the potential side effects, the woman’s overall health and age, and whether she plans on having children in the future. Treatment options include:

As a gynecologic cancer patient exploring treatment options at CTCA® Chicago, you’ll meet with a board-certified gynecologic oncologist, who oversees the various aspects of your care, and other members of your multidisciplinary care team. Using evidence-based medicine, your gynecologic oncologist will develop a unique treatment plan tailored to your specific diagnosis. Your treatment plan may include surgery, chemotherapy, radiation or another appropriate therapy, or a combination of two or more of these.

Chemotherapy deliver techniques

We also offer two sophisticated treatments: intraperitoneal chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC). With these methods of delivering chemotherapy, treatment is administered into the patient’s abdominal cavity to directly target cancerous cells.

Learn more about these chemotherapy treatments

Meet our Gynecologic Cancer Program team

The experts who make up the Gynecologic Cancer Program at CTCA Chicago are committed to offering integrative, state-of-the-art treatments for gynecologic cancer patients. Our Gynecologic Cancer Program includes a number of board-certified cancer experts, including gynecologic oncologists who have expertise in treating gynecologic malignancies using advanced technologies to fight the disease. Explore the links below to learn more about the entire team.

Julian Schink - Chief, CTCA Division of Gynecologic Oncology, Department of Surgery

Julian Schink

Chief Medical Officer and Chief, CTCA Division of Gynecologic Oncology

Herbert H. Beck III - Gynecologic Oncologist

Herbert H. Beck III

Gynecologic Oncologist, CTCA Chicago

Hatem Halabi - Assistant Director of the GI Cancer Institute

Hatem Halabi

Director, Surgical Oncology, CTCA Gastrointestinal Cancer Institute, CTCA Chicago

Kamal Patel - Medical Director, Radiation Oncology

Kamal Patel

Radiation Oncology Director, CTCA Lung Cancer Institute

Karan Shah

Radiation Oncologist, CTCA Chicago

Karen Smorowski - Radiation Oncologist

Karen Smorowski

Radiation Oncologist, CTCA Chicago

Daniel Liu - Plastic and Reconstructive Surgeon

Daniel Liu

Plastic and Reconstructive Surgeon, CTCA Chicago

Aaron Pelletier - Plastic & Reconstructive Surgeon

Aaron Pelletier

Chief of Surgery, CTCA Chicago

Bradford Tan - Chair Department of Pathology and Laboratory Medicine

Bradford Tan

Chair, CTCA Department of Pathology and Laboratory Medicine

Elham Abboud - Assistant Medical Director of Pathology and Laboratory Medicine

Elham Abboud

Assistant Medical Director of Pathology and Laboratory Medicine, CTCA Chicago

Courtney Anderson - Physician Assistant

Courtney Anderson

Physician Assistant, CTCA Chicago

Britt Hermann - Social Worker

Britt Hermann

Social Worker

More on this specialty

A comprehensive team approach

The Gynecologic Cancer Program at CTCA Chicago is committed to a multidisciplinary approach to care. After diagnosis, each patient is evaluated by a board-certified gynecologic oncologist, who then helps build the team by choosing which experts should be involved. The entire team, including supportive care clinicians, dedicated to helping patients prevent, anticipate and manage side effects, consults with one another on the range of treatment options and side-effect management tools available. Then, the doctors and clinicians work with the patient as a team, to develop a treatment plan designed to achieve pre-established goals.

This collaborative, personalized approach allows us flexibility along the treatment journey, while also fostering an environment where experts in a variety of disciplines work together, all under one roof. New options may arise or different goals may be proposed during the course of treatment. We monitor the patient throughout treatment and adjust the care plan as needed.

The CTCA national tumor board, a panel of experts who meet regularly to review and discuss each patient's treatment and monitor progress, helps enhance collaboration among physicians, especially in complex cases.

Integrative cancer care

As a patient at the Gynecologic Cancer Program at CTCA Chicago, your team also works closely with other supportive care clinicians to help manage additional disease- and treatment-related side effects, such as nausea and vomiting. These supportive care experts may include a pain management physician, naturopathic provider, mind-body therapist and spiritual support provider.

Learn more about the value of integrated cancer care

Fertility

We understand that certain cancer treatments, including chemotherapy, surgery and radiation therapy, may interfere with your fertility and prevent or complicate your ability to become pregnant. If you decide you want to preserve your fertility, we will explain potential oncofertility options before you begin treatment. If you’ve had treatments prior to coming to CTCA Chicago, we help you determine your options.

Learn more about women and cancer

"CTCA worked with me to accommodate my job schedule because I didn’t want to miss any work. I came in and did tests one day and then returned another day to get my results. I met with my care team and, most importantly, my gynecologic oncologist. Throughout the entire process, I felt I received thorough explanations, and I did not feel rushed when I had questions. "

Zorta E.

Zorta E.

Uterine Cancer

MORE ABOUT ZORTA

More About ZORTA

Gynecologic cancer clinical trials

Our oncologists are committed to improving treatment options for gynecologic cancer patients. As part of that commitment, the Gynecologic Cancer Program at CTCA Chicago offers qualified patients carefully selected clinical trials in studying new treatment approaches like immunotherapy for cervical cancer and other innovative research.

Although clinical trials are not available to all patients, they may offer some patients options that would otherwise be unavailable to them. Your care team will discuss whether you qualify for any of our ongoing clinical trials, and if so, help you enroll.

Learn more about the CTCA clinical trials program and which trials are available

Where we are located

CTCA Chicago

Gynecologic Cancer Program
2520 Elisha Ave.
Zion, IL 60099

New Patients:888-552-6760
Existing Patients: 847-510-CTCA

Get directions

Outpatient Treatment Center, Downtown Chicago

160 Illinois St.
Chicago, IL 60611

New Patients:888-552-6760
Existing Patients: 312-510-CTCA

Get directions